Stiripentol

Trade Name: 
Diacomit
Manufacturer/Distributor: 
Biocodex SA, France / Distributed by C.R.I., Dundas, Ontario
Classification: 
Antiepileptic
ATC Class: 
N03AX - other antiepileptics
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2014/12/21
Date Marketed in Canada (yyyy/mm/dd): 
2014/12/21
Presentation: 
Capsule: 250 mg. DIN: 02398958
Capsule: 500 mg. DIN: 02398966
Powder for suspension: 250 mg. DIN: 02398974
Powder for suspension: 500 mg. DIN: 02398982
Comments: 
For use in conjunction with clobazam and valproate as adjunctive therapy of refractory generalized tonic-clonic seizures in patients with severe myoclonic epilepsy in infancy (SMEI, Dravet syndrome) whose seizures are not adequately controlled with clobazam and valproate alone.